TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $3.44M2011: $6.51M2012: $391.0K2013: $155.97M2014: $150.61M2015: $58.36M2016: $49.66M2017: $69.00M2018: $118.02M2019: $128.86M2020: $85.92M2021: $190.46M2022: $135.19M2023: $52.23M2024: $62.48M2025: $60.54M$60.54M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$60.54M-3.1%
2024$62.48M+19.6%
2023$52.23M-61.4%
2022$135.19M-29.0%
2021$190.46M+121.7%
2020$85.92M-33.3%
2019$128.86M+9.2%
2018$118.02M+71.1%
2017$69.00M+38.9%
2016$49.66M-14.9%
2015$58.36M-61.3%
2014$150.61M-3.4%
2013$155.97M+39791.0%
2012$391.0K-94.0%
2011$6.51M+89.0%
2010$3.44M—